Advertisement

Oral Signs of Gastrointestinal Disease

  • John C. SteeleEmail author
Chapter

Abstract

It is often said that the mouth is “the window to the body” and thus oral signs and symptoms can frequently be the initial presentation of underlying and more significant disease that warrants further investigation. The mouth is the opening (stoma) at the proximal end of the continuum that is the gastrointestinal tract. It is, therefore, not surprising to find oral manifestations of more distally presenting enteropathic disease.

This chapter intends to discuss the epidemiology, etiopathogenesis, clinical manifestations, oral signs and symptoms, differential diagnosis, and general treatment recommendations for oral disease associated with inflammatory bowel disease (i.e., Crohn’s disease and ulcerative colitis), celiac disease, autosomal dominant syndromes (Gardner’s and Peutz-Jeghers), malabsorption conditions, and gastroesophageal reflux disease.

Keywords

oral manifestations Crohn’s disease orofacial granulomatosis ulcerative colitis pyostomatitis vegetans celiac disease Gardner’s syndrome Peutz-Jeghers syndrome malabsorption conditions gastroesophageal reflux 

References

  1. 1.
    Inflammatory Bowel Disease. Centers for Disease Control and Prevention. (CDC); 2014. http://www.cdc.gov/ibd/ Accessed 02 Oct 2014.
  2. 2.
    The Facts about Inflammatory Bowel Diseases. Crohn’s and Colitis Foundation of America; 2011. http://www.ccfa.org/assets/pdfs/ibdfactbook.pdf. Accessed 02 Oct 2014.
  3. 3.
    Sanderson J, Nunes C, Escudier M, Barnard K, Shirlaw P, Odell E, et al. Oro-facial granulomatosis: Crohn’s disease or a new inflammatory bowel disease? Inflamm Bowel Dis. 2005;11(9):84–846.CrossRefGoogle Scholar
  4. 4.
    Campbell H, Escudier M, Patel P, Nunes C, Elliott TR, Barnard K, et al. Distinguishing orofacial granulomatosis from Crohn’s disease: two separate disease entities? Inflamm Bowel Dis. 2011;17(10):2109–15.CrossRefGoogle Scholar
  5. 5.
    Zbar AP, Ben-Horin S, Beer-Gabel M, Eliakim R. Oral Crohn’s disease: is it a separable disease from orofacial granulomatosis? A review. J Crohns Colitis. 2012;6:135–42.CrossRefGoogle Scholar
  6. 6.
    Lazzerini M, Bramuzzo M, Ventura A. Association between orofacial granulomatosis and Crohn’s disease in children: systematic review. World J Gastroenterol. 2014;20(23):7497–504.CrossRefGoogle Scholar
  7. 7.
    Wiesenfeld D, Ferguson MM, Mitchell DN, MacDonald DG, Scully C, Cochran K, et al. Oro-facial granulomatosis – a clinical and pathological analysis. Q J Med. 1985;54(213):101–13.PubMedGoogle Scholar
  8. 8.
    Tilakaratne WM, Freysdottir FF. Orofacial granulomatosis: review on aetiology and pathogenesis. J Oral Pathol Med. 2008;37:191–5.CrossRefGoogle Scholar
  9. 9.
    Grave B, McCullough M, Wiesenfeld D. Orofacial granulomatosis – a 20-year review. Oral Dis. 2009;15:46–51.CrossRefGoogle Scholar
  10. 10.
    Patel P, Brostoff J, Campbell H, Goel RM, Taylor K, Ray S, et al. Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease. Clin Transl Allergy. 2013;3(1):26.CrossRefGoogle Scholar
  11. 11.
    White A, Nunes C, Escudier M, Lomer MCE, Barnard K, Shirlaw P, et al. Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis. 2006;12(6):508–14.CrossRefGoogle Scholar
  12. 12.
    Al Johani K, Moles DR, Hodgson T, Porter SR, Fedele S. Onset and progression of clinical manifestations of orofacial granulomatosis. Oral Dis. 2009;15:214–9.CrossRefGoogle Scholar
  13. 13.
    McCartan BE, Healy CM, McCreary CE, Flint SR, Rogers S, Toner ME. Characteristics of patients with orofacial granulomatosis. Oral Dis. 2011;17(7):696–704.CrossRefGoogle Scholar
  14. 14.
    Lankarani KB, Sivandzadeh GR, Hassanpour S. Oral manifestation in inflammatory bowel disease: a review. World J Gastroenterol. 2013;19(46):8571–9.CrossRefGoogle Scholar
  15. 15.
    Daley TD, Armstrong JE. Oral manifestations of gastrointestinal diseases. Can J Gastroenterol. 2007;21(4):241–4.CrossRefGoogle Scholar
  16. 16.
    Elliott T, Campbell H, Escudier M, Poate T, Nunes C, Lomer M, Mentzer A, et al. Experience with anti-TNF-α therapy for orofacial granulomatosis. J Oral Pathol Med. 2011;40:14–9.CrossRefGoogle Scholar
  17. 17.
    Hegarty A, Hodgson T, Porter S. Thalidomide for the treatment of recalcitrant oral Crohn’s disease and orofacial granulomatosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(5):576–85.CrossRefGoogle Scholar
  18. 18.
    Campbell HE, Escudier MP, Patel P, Challacombe SJ, Sanderson JD, Lomer MCE. Review article: cinnamon- and benzoate-free diet as a primary treatment for orofacial granulomatosis. Aliment Pharmacol Ther. 2011;34:687–701.CrossRefGoogle Scholar
  19. 19.
    Campbell HE, Escudier MP, Milligan P, Challacombe SJ, Sanderson JD, Lomer MC. Development pf a low phenolic acid diet for the management of orofacial granulomatosis. J Hum Nutr Diet. 2013;26(6):527–37.CrossRefGoogle Scholar
  20. 20.
    Langan RC, Gotsch PB, Krafczyk MA, Skillinge DD. Ulcerative colitis: diagnosis and treatment. Am Fam Physician. 2007;76(9):1323–30.PubMedGoogle Scholar
  21. 21.
    Elahi M, Telkabadi M, Samadi V, Vakili H. Association of oral manifestations with ulcerative colitis. Gastroenterol Hepatol Bed Bench. 2012;5(3):155–60.PubMedPubMedCentralGoogle Scholar
  22. 22.
    Hegarty AM, Barrett AW, Scully C. Pyostomatitis vegetans. Clin Exp Dermatol. 2004;29(1):1–7.CrossRefGoogle Scholar
  23. 23.
    Konstantopoulou M, O’Dwyer EM, Steele JC, Field EA, Lewis MAO, Macfarlane AW. Pyodermatitis-pyostomatitis vegetans complicated by methicillin-resistant Staphylococcus aureus infection. Clin Exp Dermatol. 2005;30(6):666–8.CrossRefGoogle Scholar
  24. 24.
    Femiano F, Lanza A, Buonaiuto C, Perillo L, Dell’Ermo A, Cirillo N. Pyostomatitis vegetans: a review of the literature. Med Oral Patol Oral Cir Bucal. 2009;14(3):E114–7.PubMedGoogle Scholar
  25. 25.
    Nico MM, Hussein TP, Aoki V, Lourenco SV. Pyostomatitis vegetans and its relation to inflammatory bowel disease, pyoderma gangrenosum, pyodermatitis vegetans, and pemphigus. J Oral Pathol Med. 2012;41(8):584–8.CrossRefGoogle Scholar
  26. 26.
    Werchniak AE, Storm CA, Plunkett RW, Beutner EH, Dinulos JG. Treatment of pyostomatitis vegetans with topical tacrolimus. J Am Acad Dermatol. 2005;52(4):722–3.CrossRefGoogle Scholar
  27. 27.
    Rivera E, Assiri A, Guandalini S. Celiac disease. Oral Dis. 2013;19(7):635–41.CrossRefGoogle Scholar
  28. 28.
    Guandalini S, Assiri A. Celiac disease. JAMA Pediatr. 2014;168(3):272–8.CrossRefGoogle Scholar
  29. 29.
    Ferraz EG, Campos Ede J, Sarmento VA, Silva LR. Pediatr Dent. 2012;34(7):485–8.PubMedGoogle Scholar
  30. 30.
    Nenna R, Guandalini S, Popp A, Kurppa. Coeliac disease. Autoimmune Dis. 2014;2014:623784.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Rashid M, Zarkadas M, Anca A, Limeback H. Oral manifestations of celiac disease: a clinical guide for dentists. J Can Dent Assoc. 2011;77:b39.PubMedGoogle Scholar
  32. 32.
    Fasano A, Berti I, Gerarduzzi T, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States. Arch Intern Med. 2003;163(3):268–92.CrossRefGoogle Scholar
  33. 33.
    Rubio-Tapia A, Ludvigsson JF, Brantner TL, Murray JA, Everhart JE. The prevalence of celiac disease in the United States. Am J Gastroenterol. 2012;107(10):1538–44.CrossRefGoogle Scholar
  34. 34.
    Costacurta M, Maturo P, Bartolino M, Docimo R. Oral manifestations of coeliac disease. A clinical-statistic study. Oral Implantol (Rome). 2010;3(1):12–9.Google Scholar
  35. 35.
    Elli L, Pigatto PD, Guzzi G, Bardella MT. New dental enamel defects in coeliac disease. Clin Exp Dermatol. 2011;36(3):309–10.CrossRefGoogle Scholar
  36. 36.
    Jurge S, Kuffer R, Scully C, Porter SR. Mucosal disease series. Number VI. Recurrent aphthous stomatitis. Oral Dis. 2006;12(1):1–21.CrossRefGoogle Scholar
  37. 37.
    Chavan M, Jain H, Diwan N, Khedkar S, Shete A, Durkar S. Recurrent aphthous stomatitis: a review. J Oral Pathol Med. 2012;41(8):577–83.CrossRefGoogle Scholar
  38. 38.
    Chimenos-Kϋstner E, Pascual M, Blanco I, Finestres F. Hereditary familial polyposis and Gardner’s syndrome: contribution of the odonto-stomatology examination in its diagnosis and a case description. Med Oral Patol Oral Cir Bucal. 2005;10(5):402–9.Google Scholar
  39. 39.
    Smud D, Augustin G, Kekez T, Kinda E, Majerovic M, Jelincic Z. Gardner’s syndrome: genetic testing and colonoscopy are indicated in adolescents and young adults with cranial osteomas: a case report. World J Gastroenterol. 2007;13(28):3900–3.CrossRefGoogle Scholar
  40. 40.
    Cankaya AB, Erdem MA, Isler SC, Cifter M, Olgac V, Kasapoglu C, et al. Oral and maxillofacial considerations in Gardner’s syndrome. Int J Med Sci. 2012;9(2):137–41.CrossRefGoogle Scholar
  41. 41.
    Cristofaro MG, Giudice A, Amantea M, Riccelli U, Giudice M. Gardner’s syndrome: a clinical and genetic study of a family. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115(3):e1–6.CrossRefGoogle Scholar
  42. 42.
    Woo VL, Abdelsayed R. Oral manifestations of internal malignancy and paraneoplastic syndromes. Dent Clin N Am. 2008;52(1):203–30.CrossRefGoogle Scholar
  43. 43.
    Higham P, Alawi F, Stoopler ET. Medical management update: Peutz Jeghers syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109(1):5–11.CrossRefGoogle Scholar
  44. 44.
    Riegert-Johnson D, Gleeson FC, Westra W, Hefferon T, Wong Kee Song LM, Spurck L, et al. In: Riegert-Johnson DL, Boardman LA, Hefferon T, Roberts M, editors. Cancer syndromes [internet]. Bethesda: National Center for Biotechnology Information (US); 2009.. 2008 Jul 18 [updated 2008 Aug 09]. http://www.ncbi.nlm.nih.gov/books/NBK1826/ Accessed 19 Sept 2014.Google Scholar
  45. 45.
    Omundsen M, Lam FF. The other colonic polyposis syndromes. ANZ J Surg. 2012;82:675–81.CrossRefGoogle Scholar
  46. 46.
    Beggs AD, Latchford AR, Vasen HFA, Moslein G, Alonso A, Aretz S, et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut. 2010;59:975–86.CrossRefGoogle Scholar
  47. 47.
    Owens SR, Greenson JK. The pathology of malabsorption: current concepts. Histopathology. 2007;50(1):64–82.CrossRefGoogle Scholar
  48. 48.
    Bizzaro N, Antico A. Diagnosis and classification of pernicious anemia. Autoimmun Rev. 2014;13(4–5):565–8.CrossRefGoogle Scholar
  49. 49.
    Hunt A, Harrington D, Robinson S. Vitamin B12 deficiency. BMJ. 2014;349:g5226.  https://doi.org/10.1136/bmj.g5226.CrossRefPubMedGoogle Scholar
  50. 50.
    Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15(41):5121–8.CrossRefGoogle Scholar
  51. 51.
    Acid Reflux (GERD) Statistics and Facts. Healthline Networks Inc; 2012. http://www.healthline.com/health/gerd/statistics. Accessed 11 Nov 2014.
  52. 52.
    Henry MA. Diagnosis and management of gastroesophageal reflux disease. Arq Bras Cir Dig. 2014;27(3):210–5.CrossRefGoogle Scholar
  53. 53.
    Pace F, Pallotta S, Tonini M, Vakil N, Bianchi Porro G. Systematic review: gastro-oesophageal reflux disease and dental lesions. Aliment Pharmacol Ther. 2008;27:1179–86.CrossRefGoogle Scholar
  54. 54.
    Liberali SAC. Oral impact of gastro-oesophageal reflux disease: a case report. Aust Dent J. 2008;53:176–9.CrossRefGoogle Scholar
  55. 55.
    NICE guidelines (CG184). Dyspepsia and gastro-oesophageal reflux disease. Investigation and management of dyspepsia, symptoms suggestive of gastro-oesophageal disease, or both. www.nice.org.uk/guidance/cg184. Accessed 26 Oct 2014.
  56. 56.
    Roman S, Kahrilas PJ. The diagnosis and management of hiatus hernia. BMJ. 2014;349:g6154.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.The Leeds Teaching Hospitals NHS TrustLeedsUK
  2. 2.Faculty of Medicine and Health, University of LeedsLeedsUK

Personalised recommendations